Name : DRAK2 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN7520975589
| Long name | DRAK2 Primary Polyclonal Antibody |
| Also known as | DRAK2 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | DRAK2 |
| Specificity | This is a highly specific antibody against DRAK2 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human DRAK2 |
| Gene ID number | 9262 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Certain serine/threonine protein kinases, DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues, DRAKs contain an N terminal kinase domain and a C terminal regulation domain, DRAKs have high sequence homology to DAP and ZIP kinases, Overexpression of DRAK2 induces apoptosis, Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases), and they represent a novel family of serine/threonine kinases, are mediators of apoptosis, such as ASK1 and RIP, which mediates apoptosis through their catalytic activities, Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | DAP kinase related apoptosis inducing protein kinase 2, DRAK 2, Death associated protein kinase related 2, ST17B_HUMAN, STK17B, Serine/threonine kinase 17b, Serine/threonine kinase 17b apoptosis inducing, Serine/threonine protein kinase 17B, DAP kinase related apoptosis inducing protein |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | DRAK2 |
| Short name | DRAK2 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | DRAK2 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 11396 |
| Gene | STK17B |
| Long gene name | serine/threonine kinase 17b |
| Synonyms gene name | serine/threonine kinase 17b (apoptosis-inducing) |
| Synonyms | DRAK2 |
| Synonyms name | death-associated protein kinase-related 2 |
| Locus | 2q32, 3 |
| Discovery year | 1999-05-21 |
| GenBank acession | AB011421 |
| Entrez gene record | 9262 |
| Pubmed identfication | 9786912 |
| Classification | Death associated protein kinases |
| Havana BLAST/BLAT | OTTHUMG00000132735 |